Skip to main content
OM logo

OM · Outset Medical, Inc. · Holdings

Track OM — free
$2.81 -0.10 (-3.44%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$53.03M
Shares
18.87M
Volume · Nov 20 81.34K Avg daily vol (3M) 140.67K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 77
Total Value: $36,661,156
Total Shares: 12,220,562

Institutional Ownership Trend

25 quarters

Holder Concentration

Share of 13F common-share value, across 77 filers with any position, options included · Δ vs Jun 30, 2026
Top Holder
22.4%
Dec 2023 → Sep 2026 · range 13.3% – 22.4%
+2.6 pts
Top 5
61.7%
Dec 2023 → Sep 2026 · range 44.5% – 63.4%
+4.8 pts
Top 10
79.0%
Dec 2023 → Sep 2026 · range 62.4% – 89.8%
+4.5 pts
HHI
1,131
Dec 2023 → Sep 2026 · range 566 – 1,131
Broadly held+197

Who Holds OM

Last 8 quarters through Sep 30, 2026

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Sep 30, 2026: 77 filers, like-for-like change -11.3%; actively managed books -7.9%; index-like books -26.6%.

Holder type Share Filers Change
Registered adviser 31.4% 35 -20.2%
Exempt adviser 24.6% 2 +9.9%
Adviser 1.7% 2 +429.1%
Bank 8.1% 14 -12.4%
Broker-dealer 0.0% 0 -100.0%
Non-US 0.1% 2 -41.3%
Holding company 27.0% 5 -6.3%
Benefit plan 0.0% 0 —
Unknown 7.2% 17 -41.0%
How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Excluded 1 holder with no observed 2026-09-30 13F.

Conviction and Crowding

77 13F filers, quarter ended Sep 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
1
1.30% of filers hold it in their top 10
Jun 30, 2026: 1
Holders above 5%
0
median weight 0.000%
Jun 30, 2026: 1
Crowding
29.7%
of shares outstanding, 79th percentile
Jun 30, 2026: 36.6%
Private-fund advisers
29.1%
of shares outstanding
Institutional ownership
65.0%
80.4% of the estimated free float
Top 10 holders
79.0%
of 13F shares, Herfindahl 0.113
Active holders
-7.9%
like-for-like share change of active filers
5% stakes on record
3
0 13D, 3 13G (1 institutional, 2 passive, 0 exempt)
How long holders have held it value-weighted 11.4 quarters
Under 1 year 18.9% 1 to 3 years 46.4% 3 years or more 34.7% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net sellers of $49,187 (1 buying, 3 selling).

Estimated Holder Cost Basis

Quarter ended Sep 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost
$11.26
estimated per share
Jun 30, 2026: $10.46
Quarter-end price
$3.00
implied by 13F values
Estimated gain or loss
-73.4%
price against the estimated cost
Estimated at a loss
100.0%
of costed 13F value

Estimated cost covers 43.0% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shared Holders

Companies OM's active holders also own, quarter ended Sep 30, 2026
# Company Shared holders
1 FRNM Freenome, Inc. 3
2 ENGN enGene Therapeutics Inc. 3
3 IRTC iRhythm Holdings, Inc. 3
4 AMLX Amylyx Pharmaceuticals, Inc. 3
5 RYTM Rhythm Pharmaceuticals, Inc. 3
6 CELC Celcuity Inc. 3
7 ASND Ascendis Pharma A/S 3
8 BMRN Biomarin Pharmaceutical Inc 3
9 GH Guardant Health, Inc. 3
10 WAT Waters Corp 3

Shareholder Targets

13F filers that own its peers but not OM, quarter ended Sep 30, 2026

Found through its holder-overlap peers: FRNM, ENGN, IRTC, AMLX, RYTM, CELC, ASND, BMRN, GH, WAT, EW, GOOGL. 6,410 filers in all.

# Filer In peers
1 VANGUARD PORTFOLIO MANAGEMENT LLC Registered adviser, Diversified active $66,237,388,568 10 held
2 Invesco Ltd. Adviser, Diversified active $56,923,936,521 10 held
3 Capital World Investors Adviser, Diversified active $45,520,396,209 3 held
4 Capital Research Global Investors Adviser, Diversified active $36,844,775,936 5 held
5 Berkshire Hathaway Inc Insurer, Concentrated $36,374,651,401 1 held
6 UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Registered adviser, Index-like $32,548,475,150 10 held
7 CHARLES SCHWAB INVESTMENT MANAGEMENT INC Registered adviser, Diversified active $27,293,936,010 11 held
8 Capital International Investors Adviser, Diversified active $24,664,646,742 3 held
9 Legal & General Group Plc Unknown, Index-like $23,857,268,959 10 held
10 WELLINGTON MANAGEMENT GROUP LLP Holding company, Diversified active $23,217,788,203 9 held

Fund Ownership of OM by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 7.59% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 2.47% 466,265
Index ETFs 5.12% 966,127
Active ETFs 0.60% 113,627
Active funds 14.30% 2,698,603
Unclassified 0.14% 26,943
All registered funds 22.63% 4,271,565
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Quarterly Activity

vs Jun 30, 2026
New
9
Increased
13
Decreased
36
Sold Out
24
Unchanged
19

New and Sold Out count only filers that reported a 13F for both quarters: a first-time filer's book is not a buy, and a fund that has not filed, or withheld its positions under confidential treatment, has not sold.

Holder count: -16
Institutional value: -38.8%
Shares held: -11.8%

Top Buyers

vs Jun 30, 2026
Institution Added Now Holds Open

Top Sellers

vs Jun 30, 2026
Institution Sold Now Holds Open

Top New Positions

vs Jun 30, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Jun 30, 2026
Institution Previously Held Last Value (USD) Open
Showing 79 of 79
Export CSV
Holder Value (USD) % of 13F Shares Own % Change Type Filed Open
Key facts CIK 1484612 CUSIP 690145206 13F (30d) 85 filings 70 filers Visit website Investor relations